Nuvation Bio (NUVB) Total Non-Current Liabilities (2023 - 2025)
Historic Total Non-Current Liabilities for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to $273.9 million.
- Nuvation Bio's Total Non-Current Liabilities rose 30310.93% to $273.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $273.9 million, marking a year-over-year increase of 30310.93%. This contributed to the annual value of $74.8 million for FY2024, which is 36714.35% up from last year.
- According to the latest figures from Q3 2025, Nuvation Bio's Total Non-Current Liabilities is $273.9 million, which was up 30310.93% from $272.0 million recorded in Q2 2025.
- In the past 5 years, Nuvation Bio's Total Non-Current Liabilities ranged from a high of $273.9 million in Q3 2025 and a low of $15.3 million during Q1 2023
- For the 3-year period, Nuvation Bio's Total Non-Current Liabilities averaged around $82.1 million, with its median value being $61.2 million (2024).
- Examining YoY changes over the last 5 years, Nuvation Bio's Total Non-Current Liabilities showed a top increase of 36714.35% in 2024 and a maximum decrease of 1304.49% in 2024.
- Over the past 3 years, Nuvation Bio's Total Non-Current Liabilities (Quarter) stood at $16.0 million in 2023, then soared by 367.14% to $74.8 million in 2024, then surged by 266.3% to $273.9 million in 2025.
- Its Total Non-Current Liabilities stands at $273.9 million for Q3 2025, versus $272.0 million for Q2 2025 and $70.2 million for Q1 2025.